Author: Lowell McLaughlin, 2025 Summer
Student-At-Law
Eli Science Inc. ("Eli
Health"), a Montreal-based startup, has secured C
$17 million
in Series A funding to launch its at-home hormone monitoring
technology. This round of investment was led by Montreal-based Accelia Capital and
Vancouver's Telus Global
Ventures, among others. Eli Health's funding to date now
totals approximately C$28 million.
The innovative technology will initially focus on monitoring
Cortisol (a stress hormone) and Progesterone (a reproductive
hormone) through a saliva-based hormone-testing solution, tracked
via the Eli Health mobile app. The product aims to eliminate costly and
time-intensive traditional lab tests. Users can complete the
at-home test in just 60 seconds and utilize the app to receive
personalized data and recommendations related to stress management,
athletic performance, fertility and more.